Trial site
Azienda Ospedaliero-Universitaria Ss Antonio E Biagio E Cesare Arrigo
- 17running trials
- 4closed trials
The trials here
What the 21 trials at this site are about, from their registry records.
- Conditions
- Chronic lymphocytic leukaemia3 trials
- Lung cancer3 trials
- Mantle cell lymphoma3 trials
- Myeloproliferative neoplasms3 trials
- Follicular lymphoma2 trials
- Acute myeloid leukaemia1 trial
- Chronic kidney disease1 trial
- Chronic myeloid leukaemia1 trial
- Diffuse large B-cell lymphoma1 trial
- Idiopathic pulmonary fibrosis1 trial
- Myelodysplastic syndromes1 trial
- Ulcerative colitis1 trial
- Phase
- Phase 313 trials
- Phase 25 trials
- Phase 1/21 trial
- Phase 2/31 trial
- Phase 41 trial
- Status
- Active, not recruiting10 trials
- Recruiting7 trials
- Completed4 trials
- Lead sponsor
- Loxo Oncology, Inc.3 trials
- Fondazione Italiana Linfomi - ETS2 trials
- Fondazione Italiana Linfomi Ets2 trials
- Gruppo Italiano Malattie EMatologiche dell'Adulto2 trials
- Acerta Pharma BV1 trial
- and 11 more
Running trials
Recruiting
A study evaluating the effects of filgotinib in children and teenagers with ulcerative colitis
Recruiting
Active, not recruiting
Recruiting
Adding Navtemadlin to Ruxolitinib for Patients with Myelofibrosis
Active, not recruiting
Active, not recruiting
Bomedemstat vs Hydroxyurea for Essential Thrombocythemia (MK-3543-007)
Active, not recruiting
Recruiting
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Feasibility of Allogeneic Stem Cell Transplantation in Higher-risk-MDS (ACROBAT)
Recruiting
Gemtuzumab Chemotherapy MRD Levels; Adult Untreated, de Novo, Fav Interm Risk AML
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Acute myeloid leukaemia1 recruiting
- Chronic lymphocytic leukaemia1 recruiting
- Lung cancer1 recruiting
- Mantle cell lymphoma1 recruiting
- Myelodysplastic syndromes1 recruiting
- Myeloproliferative neoplasms1 recruiting
- Ulcerative colitis1 recruiting
Closed trials
Completed
Completed
Completed
Completed
Acalabrutinib, Obinutuzumab and Chlorambucil in Treatment naïve CLL
Site data: EU CTIS (euclinicaltrials.eu)Updated 17 Nov 2026